|
(V1660)
|
Die Bedeutung von SIRT1 in der Regulation kardiovaskulären oxidativen Stress
|
|
H. Li, N. Xia, A. Daiber, A. Habermeier, G. Spanier, Q. Lu, M. Oelze, E. Closs, T. Münzel, U. Förstermann (Mainz)
|
|
(V1661)
|
Pentaerithrityl tetranitrate improves angiotensin-II induced vascular oxidative stress and vascular dysfunction via induction of heme oxygenase-1
|
|
S. Schuhmacher, P. Wenzel, E. Schulz, M. Oelze, J. Kamuf, T. Gori, H. Li, U. Förstermann, T. Münzel, A. Daiber (Mainz)
|
|
(V1662)
|
CB1 receptor inhibition down-regulates vascular AT1 receptor expression: Impact on oxidative stress in vitro and in vivo
|
|
V. Tiyerili, S. Zimmer, S. Jung, G. Nickenig (Bonn)
|
|
(V1663)
|
Atorvastatin reduces the expression of aldose reductase in HUVEC. A novel approach to influence the polyol pathway and a new pleiotropic effect of atorvastatin.
|
|
T. Ruf, U. Göttmann (Dresden, Mannheim)
|
|
(V1664)
|
BMPER wird durch Statine reguliert und vermittelt pleiotrope Effekte von Statinen am Endothel
|
|
T. Helbing, R. Rothweiler, J. Heinke, L. Goetz, A. Zirlik, C. Bode, M. Moser (Freiburg im Breisgau)
|
|
(V1665)
|
The anti-inflammatory effects of the AMP-activated protein kinase (AMPK) are mediated by attenuation of NFκB phosphorylation and activity
|
|
B. Fißlthaler, E. Bess, I. Fleming (Frankfurt am Main)
|